Figure S1 from PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma

Authors:

Open Access

Supplementary Figure 1 shows clustering of drug-treated cells compared to controls.